1. Home
  2. Labeler Index
  3. Ipsen Biopharmaceuticals, Inc.
  4. 15054-1090
  5. Product Images: Somatuline Depot

Product Images Somatuline Depot

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Chemical Structure - somatuline 01
  2. Figure 1 - somatuline 02
  3. Figure - somatuline 03
  4. Figure - somatuline 04
  5. Figure - somatuline 05
  6. Figure - somatuline 07
  7. Figure - somatuline 08
  8. Figure - somatuline 09
  9. Figure - somatuline 10
  10. Figure - somatuline 11
  11. Figure - somatuline 12
  12. Figure - somatuline 13
  13. somatuline 13a
  14. Figure - somatuline 14
  15. Figure - somatuline 15
  16. Figure - somatuline 16
  17. Figure - somatuline 17
  18. Figure - somatuline 18
  19. Figure - somatuline 19
  20. Figure - somatuline 20
  21. somatuline 20a
  22. Figure - somatuline 21
  23. Figure - somatuline 22
  24. Figure - somatuline 23
  25. Figure - somatuline 24
  26. somatuline 24a
  27. Figure - somatuline 25
  28. Figure - somatuline 26
  29. Figure - somatuline 27
  30. Figure - somatuline 28
  31. Figure - somatuline 29
  32. PRINCIPAL DISPLAY PANEL - 60 mg/0.2 mL Syringe Carton - somatuline 30
  33. PRINCIPAL DISPLAY PANEL - 90 mg/0.3 mL Syringe Carton - somatuline 31
  34. PRINCIPAL DISPLAY PANEL - 120 mg/0.5 mL Syringe Carton - somatuline 32

Product Label Images

The following 34 images provide visual information about the product associated with Somatuline Depot NDC 15054-1090 by Ipsen Biopharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - somatuline 01

Chemical Structure - somatuline 01

Figure 1 - somatuline 02

Figure 1 - somatuline 02

This is a medical report showing the progression-free survival probability of two groups of subjects. The report displays a graph with the percentage of survival probability on the y-axis and time in months on the x-axis. The two groups being compared are Somatuline Depot with 101 subjects and Placebo with 97 subjects. The report also shows the Hazard Ratio (HR) with a value of 0.47 and a statistical significance of P<0.001. The numbers below the graph indicate the number of subjects still at risk and the corresponding time in months.*

Figure - somatuline 03

Figure - somatuline 03

This text suggests that the box being evaluated appears undamaged, and the expiration date has not yet passed.*

Figure - somatuline 04

Figure - somatuline 04

This document appears to be a prescription instruction for the drug dose of a medication. The medication can be taken at three different dosage levels: 60mg, 90mg, or 120mg. The text advises the patient to take the medication dose as prescribed.*

Figure - somatuline 05

Figure - somatuline 05

Figure - somatuline 07

Figure - somatuline 07

Figure - somatuline 08

Figure - somatuline 08

Figure - somatuline 09

Figure - somatuline 09

Figure - somatuline 10

Figure - somatuline 10

Figure - somatuline 11

Figure - somatuline 11

Figure - somatuline 12

Figure - somatuline 12

Figure - somatuline 13

Figure - somatuline 13

somatuline 13a

somatuline 13a

Figure - somatuline 14

Figure - somatuline 14

Figure - somatuline 15

Figure - somatuline 15

Figure - somatuline 16

Figure - somatuline 16

Figure - somatuline 17

Figure - somatuline 17

Figure - somatuline 18

Figure - somatuline 18

Figure - somatuline 19

Figure - somatuline 19

Figure - somatuline 20

Figure - somatuline 20

somatuline 20a

somatuline 20a

Figure - somatuline 21

Figure - somatuline 21

Figure - somatuline 22

Figure - somatuline 22

Figure - somatuline 23

Figure - somatuline 23

Figure - somatuline 24

Figure - somatuline 24

somatuline 24a

somatuline 24a

Figure - somatuline 25

Figure - somatuline 25

Figure - somatuline 26

Figure - somatuline 26

Figure - somatuline 27

Figure - somatuline 27

Figure - somatuline 28

Figure - somatuline 28

Figure - somatuline 29

Figure - somatuline 29

PRINCIPAL DISPLAY PANEL - 60 mg/0.2 mL Syringe Carton - somatuline 30

PRINCIPAL DISPLAY PANEL - 60 mg/0.2 mL Syringe Carton - somatuline 30

Somatuline Depot is a drug that is injected subcutaneously and contains 60 mg/0.2 mL of lanreotide. It should be refrigerated at 2°C - 8°C and protected from light in its original package. If there are any questions about the drug, individuals can call 1-855-463-5127. It is manufactured by Ipsen Pharma Biotech in France and distributed by Ipsn Biopharmaceuticals in Cambridge, MA. The drug should be administered by a healthcare professional and is for single use only. Unused portions should be discarded, and it should be left at room temperature for 30 minutes before administration.*

PRINCIPAL DISPLAY PANEL - 90 mg/0.3 mL Syringe Carton - somatuline 31

PRINCIPAL DISPLAY PANEL - 90 mg/0.3 mL Syringe Carton - somatuline 31

PRINCIPAL DISPLAY PANEL - 120 mg/0.5 mL Syringe Carton - somatuline 32

PRINCIPAL DISPLAY PANEL - 120 mg/0.5 mL Syringe Carton - somatuline 32

This is a product description of Somatuline Depot, manufactured in France and distributed in the US, designed for deep subcutaneous injection. It comes in a 120mg/0.5 mL dosage and should only be used once. The instructions advise leaving it at room temperature for 30 minutes before being administered by a healthcare professional. The product is distributed by Ipsen Biopharmaceuticals and stored in a refrigerator between 36°F and 46°F. In case customers have any questions about the product, they can call 1-855-463-5127.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.